Talk:Signal transduction
This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards. |
Signal transduction is the mechanism by which a signal is transmitted through cell to induce the appropriate response. Most psychoactive drugs influence signal transduction of neurons by interacting with extracellular receptors - either activating them, blocking them or changing the way they are activated by endogenous ligands (known as allosteric modulation). Others, such as most stimulants or MAO inhibitors, affect the metabolism or transport of endogenous ligands. However, understanding the ways drugs act on specific intracellular signaling components is an interest of many researchers, as it can provide better insights to the nature of their effects and potential dangers [1].
General overview
A signal transduction pathway generally includes a ligand, a receptor, primary and secondary effectors and “secondary messengers”.
Ligand
A ligand is any chemical that binds to a receptor. Endogenous ligands are of various chemical nature, including proteins, amines, amino acids, or even gases. Ligands that mediate signal between neurons are called neurotransmitters. Some psychoactive drugs directly “imitate” neurotransmitters, but the ligand-receptor binding is complicated and usually cannot be predicted by simple similarity in 2D structure alone [2].
A neuron usually produces only one type of “primary” neurotransmitter, but can also produce additional neuromodulators (sometimes less accurately also referred to as neurotransmitters [3]). Various peptides, cannabinoids, or nitric oxide are usually categorized as neuromodulators. Different types of neurons express different quantities of neurotransmitter receptors. This creates neurotransmitter pathways (or systems), such as the serotoninergic, dopaminergic or cholinergic system.
Examples of neurotransmitters:
- Glutamate
- GABA
- Acetylcholine
- Dopamine
- Serotonin
- Noradrenaline
- Endogenous opioids - function both as neurotransmitters and neuromodulators [4]
Examples of other relevant ligands:
- Neurotrophic factors - role in neurogenesis and mood, possibly responsible for the anitdepressant effects of ketamine [5].
- Ligands of developmental pathways - Akt/mTOR, Notch, Hedgehog... (some drugs, for example alcohol, modulate these pathways and negatively affect development when consumed by children or during pregnancy.
Receptor
Additional information available in the article Receptor
A receptor is a specialized protein that detects the presence of a stimulus - such as mechanical force, light, or a ligand. Receptors can be present on the cell membrane, but also inside the cell. Psychoactive drugs and most endogenous ligands usually target extracellular receptors because, due to their chemical properties, they are not able to enter the cell. However, for example amphetamines activate the intracellular trace amine associated receptor (TAAR) [6], as they can enter the cell via transporters for dopamine or noradrenaline.
Most common extracellular receptors are:
- Ligand-gated ion channels - these are channels in the membrane that open when activated by ligands. When open, they let specific ions (Na+, Ca2+, K+, Cl-…) either in or out of the cell, which changes the membrane potential and allows for very fast signal transmission. Examples of ligand-gated ion channels include NMDA receptors - targets of dissociatives, or GABA-A receptors - targets of many depressants.
- G-protein coupled receptors (GPCRs) - most common receptors in animal cells, when activated they pass the signal to an associated trimeric G protein. This is a small protein that travels on the intracellular side of the membrane and activates or inhibits the production of secondary messengers. There are different types of GPCRs, and can be both excitatory and inhibitory. Examples include serotonin receptors (besides 5-HT3) - targets of most psychedelics, as well as opioid receptors.
- Receptors with enzymatic activity - when activated they begin catalyzing a biochemical reaction. This reaction is most often phosphorylation which works as an on/off switch for other enzymes or signaling components. Examples are receptors for growth factors.
Secondary messengers
“Secondary messengers” is an arbitrary term for several small molecules that are able to transfer and amplify the signal inside of the cell. These are:
- Calcium ions - an important signaling component in many processes in the brain. Too much calcium can induce cell death. This is why NMDAR antagonists, like ketamine or memantine have neuroprotective effects and can be used for the management of Alzheimer’s disease [7].
- Inositol triphosphate (IP3) and diacylglycerol (DAG) - these molecules is released after cleavage of membrane lipids catalyzed by phospholipase C. This process is most commonly activated by GPCRs with a Galpha q subunit (for example 5-HT2A). However, both DAG and IP3 in turn increases calcium concentration, so PLC signaling is linked with Ca signaling.
- Cyclic AMP (cAMP) - a molecule produced by the enzyme adenylate cyclase, activated by GPCRs with a Galpha s subunit (for example D1) and inhibited by Galpha i (for example GABA-B). The effects of cAMP are mostly mediated through protein kinase A.
Macromolecular effectors
Most complicated part of signal transduction are the networks of interacting proteins, typically enzymes. Most common enzymes involved in signaling are kinases - enzymes that catalyze the addition of phosphate to a molecule. A large group of kinases, known as protein kinases, add phosphates to other proteins. This often results in complex cascades of phosphorylation, in which kinases phosphorylate other kinases, often several times before the signal is "complete" [8].
Response
A signal transduction pathway can induce a cellular response in various ways, usually multiple in parallel. The fastest type of response is the change in membrane potential, caused by the transport of ions between the cell and extracellular space. Increase in membrane potential may activate additional channels, voltage-gated ion channels. This way, electrical signal can quickly spread even in long neurons. Change in membrane potential doesn’t have to be a result of ligand-gated channel activation. Activation of opioid receptors (GPCRs), for example, indirectly causes the opening of potassium channels, which is partially responsible for its analgesic effects [9].
Another possible response is the change in metabolic processes of the cell. Many signaling pathways, such as the one activated by insulin, affect the intake, decomposition or synthesis of nutrients.
The final effect of a signaling pathway is the change in gene expression. This is mediated by transcription factors that bind to the DNA in the nucleus. This can result in significant long-term effects on the whole organism. Change in gene expression is thought to play a role in the development of addiction or tolerance [10].
References
- ↑ Slocum, S. T., DiBerto, J. F., & Roth, B. L. (2021). Molecular insights into psychedelic drug action. In Journal of Neurochemistry (Vol. 162, Issue 1, pp. 24–38). Wiley. https://doi.org/10.1111/jnc.15540
- ↑ Doytchinova I. Drug Design-Past, Present, Future. Molecules. 2022 Feb 23;27(5):1496. doi: 10.3390/molecules27051496. PMID: 35268598; PMCID: PMC8911833.
- ↑ Burrows, Malcolm, 'Neurotransmitters, neuromodulators and neurohormones ', The Neurobiology of an Insect Brain (Oxford, 1996; online edn, Oxford Academic, 22 Mar. 2012), https://doi.org/10.1093/acprof:oso/9780198523444.003.0005, accessed 22 Nov. 2023.
- ↑ Shenoy SS, Lui F. Biochemistry, Endogenous Opioids. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532899/
- ↑ Deyama S, Duman RS. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav. 2020 Jan;188:172837. doi: 10.1016/j.pbb.2019.172837. Epub 2019 Dec 9. PMID: 31830487; PMCID: PMC6997025.
- ↑ Liu, H., Zheng, Y., Wang, Y. et al. Recognition of methamphetamine and other amines by trace amine receptor TAAR1. Nature 624, 663–671 (2023). https://doi.org/10.1038/s41586-023-06775-1
- ↑ Jain KK. Evaluation of memantine for neuroprotection in dementia. Expert Opin Investig Drugs. 2000 Jun;9(6):1397-406. doi: 10.1517/13543784.9.6.1397. PMID: 11060751.
- ↑ Boris N Kholodenko; Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors. J Exp Biol 15 June 2003; 206 (12): 2073–2082. doi: https://doi.org/10.1242/jeb.00298
- ↑ Ikeda K, Kobayashi T, Kumanishi T, Niki H, Yano R. Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia. Neurosci Res. 2000 Sep;38(1):113-6. doi: 10.1016/s0168-0102(00)00144-9. PMID: 10997585.
- ↑ Bali, P., & Kenny, P. J. (2019). Transcriptional mechanisms of drug addiction . Dialogues in Clinical Neuroscience, 21(4), 379–387. https://doi.org/10.31887/DCNS.2019.21.4/pkenny